Syros Pharmaceuticals, Inc. (SYRS) Retained Earnings (Accumulated Deficit) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Syros Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2015 to 2024.
  • Syros Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$727 M, a 24.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$727 M -$144 M -24.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$723 M -$165 M -29.5% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 -$658 M -$105 M -19% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$618 M -$95.1 M -18.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$582 M -$93.3 M -19.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$558 M -$94.7 M -20.4% Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$553 M -$114 M -25.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$523 M -$109 M -26.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$489 M -$97.5 M -24.9% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$464 M -$86.6 M -23% Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$440 M -$92.9 M -26.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 -$414 M -$86.3 M -26.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$391 M -$81 M -26.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$377 M -$84 M -28.7% Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$347 M -$73.6 M -26.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$327 M -$73.9 M -29.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$310 M -$76.2 M -32.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$293 M -$75.4 M -34.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$273 M -$73.7 M -37% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$253 M -$69.7 M -37.9% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 -$234 M -$64.3 M -37.9% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 -$218 M -$62.3 M -40.1% Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$200 M -$59.5 M -42.5% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 -$184 M -$57.6 M -45.7% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$170 M -$57 M -50.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$155 M -$54 M -53.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$140 M -$49.7 M -55% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$126 M -$50 M -65.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$113 M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$101 M -$47.7 M -89.2% Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$90.3 M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 -$76.1 M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 -$53.5 M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.